MICHAEL F MAGUIRE M.D.
Prescription History 1124186721
Internal Medicine - Critical Care Medicine in Appleton, WI
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MICHAEL F MAGUIRE M.D., an active Critical Care Medicine specialist practicing in Appleton, WI. Our medical registry currently tracks 29 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,406 documented patient claims. Among these therapy options, the most frequently utilized medication is Albuterol Sulfate Hfa, which accounts for 196 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other WI PrescribersVs. WI Avg |
|---|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 196 | $35.11▼ below WI avg | ▲ More than typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾ It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2023, this provider wrote 196 Medicare prescriptions for Albuterol Sulfate Hfa, about 3.6 times the volume of the typical Wisconsin prescriber of this medication (55). Medicare paid an average of $35.11 per fill, versus $51.37 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 274.1 30-Day Fills standardized to 30-day supplies 6,489 Days of Medication total across all patients in 2023 | |||
| Montelukast Sodium | 180 | $14.63▼ below WI avg | ▲ More than typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. In 2023, this provider wrote 180 Medicare prescriptions for Montelukast Sodium, about 4.2 times the volume of the typical Wisconsin prescriber of this medication (43). Medicare paid an average of $14.63 per fill, versus $18.69 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 415.2 30-Day Fills standardized to 30-day supplies 12,445 Days of Medication total across all patients in 2023 | |||
| Breo ElliptaFluticasone/Vilanterol | 112 | $525.85▼ below WI avg | ▲ More than typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 112 Medicare prescriptions for Breo Ellipta, about 3.5 times the volume of the typical Wisconsin prescriber of this medication (32). Medicare paid an average of $525.85 per fill, versus $529.05 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 140 30-Day Fills standardized to 30-day supplies 4,200 Days of Medication total across all patients in 2023 | |||
| Wixela InhubFluticasone Propion/Salmeterol | 92 | $308.90▼ below WI avg | ▲ More than typical |
About Wixela Inhub: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 92 Medicare prescriptions for Wixela Inhub, about 4 times the volume of the typical Wisconsin prescriber of this medication (23). Medicare paid an average of $308.90 per fill, versus $314.02 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 132 30-Day Fills standardized to 30-day supplies 3,960 Days of Medication total across all patients in 2023 | |||
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 92 | $887.94 | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2023, this provider wrote 92 Medicare prescriptions for Trelegy Ellipta, about 1.7 times the volume of the typical Wisconsin prescriber of this medication (54). Medicare paid an average of $887.94 per fill, versus $820.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 122 30-Day Fills standardized to 30-day supplies 3,660 Days of Medication total across all patients in 2023 | |||
| Prednisone | 78 | $7.24 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 78 Medicare prescriptions for Prednisone, about 1.9 times the volume of the typical Wisconsin prescriber of this medication (41). Medicare paid an average of $7.24 per fill, versus $7.04 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 106.1 30-Day Fills standardized to 30-day supplies 2,797 Days of Medication total across all patients in 2023 | |||
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 68 | $282.87 | ▲ More than typical |
About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 68 Medicare prescriptions for Fluticasone-Salmeterol, about 3 times the volume of the typical Wisconsin prescriber of this medication (23). Medicare paid an average of $282.87 per fill, versus $250.28 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 101 30-Day Fills standardized to 30-day supplies 3,030 Days of Medication total across all patients in 2023 | |||
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 63 | $631.27 | ▲ More than typical |
About Anoro Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2023, this provider wrote 63 Medicare prescriptions for Anoro Ellipta, about 1.9 times the volume of the typical Wisconsin prescriber of this medication (34). Medicare paid an average of $631.27 per fill, versus $574.75 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 83 30-Day Fills standardized to 30-day supplies 2,490 Days of Medication total across all patients in 2023 | |||
| Flovent HfaFluticasone Propionate | 62 | $326.68▼ below WI avg | ▲ More than typical |
About Flovent Hfa: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2023, this provider wrote 62 Medicare prescriptions for Flovent Hfa, about 2.8 times the volume of the typical Wisconsin prescriber of this medication (22). Medicare paid an average of $326.68 per fill, versus $442.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 62 30-Day Fills standardized to 30-day supplies 1,860 Days of Medication total across all patients in 2023 | |||
| Incruse ElliptaUmeclidinium Bromide | 51 | $419.71▼ below WI avg | ▲ More than typical |
About Incruse Ellipta: Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 51 Medicare prescriptions for Incruse Ellipta, about 2 times the volume of the typical Wisconsin prescriber of this medication (26). Medicare paid an average of $419.71 per fill, versus $464.80 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 57 30-Day Fills standardized to 30-day supplies 1,710 Days of Medication total across all patients in 2023 | |||
| SymbicortBudesonide/Formoterol Fumarate | 49 | $641.86 | ▲ More than typical |
About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2023, this provider wrote 49 Medicare prescriptions for Symbicort, about 1.5 times the volume of the typical Wisconsin prescriber of this medication (32). Medicare paid an average of $641.86 per fill, versus $527.31 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 82 30-Day Fills standardized to 30-day supplies 2,460 Days of Medication total across all patients in 2023 | |||
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 34 | $615.90 | ≈ Typical |
About Stiolto Respimat: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: tiotropium and olodaterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Olodaterol belongs to the class of drugs known as long-acting inhaled beta-agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Tiotropium/olodaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as olodaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2023, this provider wrote 34 Medicare prescriptions for Stiolto Respimat, about the same volume as the typical Wisconsin prescriber of this medication (37). Medicare paid an average of $615.90 per fill, versus $613.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2023 | |||
| Combivent RespimatIpratropium/Albuterol Sulfate | 33 | $595.08▼ below WI avg | ▲ More than typical |
About Combivent Respimat: This product is used to treat and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ This product contains 2 medications: ipratropium and albuterol (also known as salbutamol). Both drugs work by relaxing the muscles around the airways so that the airways open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. In 2023, this provider wrote 33 Medicare prescriptions for Combivent Respimat, about 1.6 times the volume of the typical Wisconsin prescriber of this medication (21). Medicare paid an average of $595.08 per fill, versus $642.39 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 44 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2023 | |||
| Spiriva HandihalerTiotropium Bromide | 29 | $714.34▼ below WI avg | ≈ Typical |
About Spiriva Handihaler: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2023, this provider wrote 29 Medicare prescriptions for Spiriva Handihaler, about 1.2 times the volume of the typical Wisconsin prescriber of this medication (25). Medicare paid an average of $714.34 per fill, versus $783.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,170 Days of Medication total across all patients in 2023 | |||
| Modafinil | 29 | $58.54▼ below WI avg | ▲ More than typical |
About Modafinil: Modafinil reduces extreme sleepiness due to narcolepsy and other sleep disorders, such as periods of stopped breathing during sleep (obstructive sleep apnea). Show more ▾ It is also used to help you stay awake during work hours if you have a work schedule that keeps you from having a normal sleep routine (shift work sleep disorder). This medication does not cure these sleep disorders and may not get rid of all your sleepiness. Modafinil does not take the place of getting enough sleep. It should not be used to treat tiredness or hold off sleep in people who do not have a sleep disorder. It is not known how modafinil works to keep you awake. It is thought to work by affecting certain substances in the brain that control the sleep/wake cycle. A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS. In 2023, this provider wrote 29 Medicare prescriptions for Modafinil, about 1.3 times the volume of the typical Wisconsin prescriber of this medication (22). Medicare paid an average of $58.54 per fill, versus $175.92 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2023 | |||
| Fluticasone Propionate | 28 | $18.22▼ below WI avg | ▼ Less than typical |
About Fluticasone Propionate: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2023, this provider wrote 28 Medicare prescriptions for Fluticasone Propionate, about half the volume of the typical Wisconsin prescriber of this medication (47). Medicare paid an average of $18.22 per fill, versus $18.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 62.7 30-Day Fills standardized to 30-day supplies 1,880 Days of Medication total across all patients in 2023 | |||
| Azithromycin | 26 | $6.34▼ below WI avg | ≈ Typical |
About Azithromycin: This medication is used to treat certain eye infections. Show more ▾ It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2023, this provider wrote 26 Medicare prescriptions for Azithromycin, about the same volume as the typical Wisconsin prescriber of this medication (27). Medicare paid an average of $6.34 per fill, versus $12.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 26.1 30-Day Fills standardized to 30-day supplies 389 Days of Medication total across all patients in 2023 | |||
| OfevNintedanib Esylate | 24 | $12,753.02 | ≈ Typical |
About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾ Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease. In 2023, this provider wrote 24 Medicare prescriptions for Ofev, about 89% of the volume of the typical Wisconsin prescriber of this medication (27). Medicare paid an average of $12,753.02 per fill, versus $12,285.82 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2023 | |||
| Arnuity ElliptaFluticasone Furoate | 21 | $235.44▼ below WI avg | ≈ Typical |
About Arnuity Ellipta: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 21 Medicare prescriptions for Arnuity Ellipta, about 78% of the volume of the typical Wisconsin prescriber of this medication (27). Medicare paid an average of $235.44 per fill, versus $311.16 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
| Spiriva RespimatTiotropium Bromide | 17 | $541.90▼ below WI avg | ▼ Less than typical |
About Spiriva Respimat: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2023, this provider wrote 17 Medicare prescriptions for Spiriva Respimat, about half the volume of the typical Wisconsin prescriber of this medication (30). Medicare paid an average of $541.90 per fill, versus $676.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Roflumilast | 16 | $135.78▼ below WI avg | ≈ Typical |
About Roflumilast: Roflumilast is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis). Show more ▾ It should be used along with other medications (bronchodilators such as salmeterol, ipratropium) to treat COPD. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 16 Medicare prescriptions for Roflumilast, about the same volume as the typical Wisconsin prescriber of this medication (15). Medicare paid an average of $135.78 per fill, versus $281.38 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2023 | |||
| XyremSodium Oxybate | 15 | $18,473.47 | ▼ Less than typical |
About Xyrem: This medication is used to treat narcolepsy, a condition that causes severe daytime sleepiness. Show more ▾ Sodium oxybate can decrease daytime sleepiness and also reduce the number of sudden short attacks of weak/paralyzed muscles (known as cataplexy) that can occur in patients with narcolepsy. Sodium oxybate is a central nervous system depressant. It is also known as gamma hydroxybutyrate (GHB). The sodium salt of 4-hydroxybutyric acid. It is used for both induction and maintenance of ANESTHESIA. In 2023, this provider wrote 15 Medicare prescriptions for Xyrem, about 71% of the volume of the typical Wisconsin prescriber of this medication (21). Medicare paid an average of $18,473.47 per fill, versus $16,259.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
| NucalaMepolizumab | 15 | $3,906.43 | ≈ Typical |
About Nucala: This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Mepolizumab is also used to treat certain other immune system disorders (chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome). This medication works by decreasing a certain type of white blood cell (eosinophils). This effect helps reduce swelling (inflammation) of the airways to make breathing easier. It may also help reduce the size of nasal polyps, and lessen symptoms such as runny/stuffy nose, mucus in the throat, loss of smell, facial pain, and tiredness. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed. In 2023, this provider wrote 15 Medicare prescriptions for Nucala, about 83% of the volume of the typical Wisconsin prescriber of this medication (18). Medicare paid an average of $3,906.43 per fill, versus $3,676.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2023 | |||
| Ventolin HfaAlbuterol Sulfate | 14 | $115.20 | ▼ Less than typical |
About Ventolin Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾ It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2023, this provider wrote 14 Medicare prescriptions for Ventolin Hfa, about half the volume of the typical Wisconsin prescriber of this medication (24). Medicare paid an average of $115.20 per fill, versus $80.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.7 30-Day Fills standardized to 30-day supplies 732 Days of Medication total across all patients in 2023 | |||
| DalirespRoflumilast | 13 | $668.21 | ▼ Less than typical |
About Daliresp: Roflumilast is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis). Show more ▾ It should be used along with other medications (bronchodilators such as salmeterol, ipratropium) to treat COPD. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 13 Medicare prescriptions for Daliresp, about a third of the volume of the typical Wisconsin prescriber of this medication (31). Medicare paid an average of $668.21 per fill, versus $547.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 306 Days of Medication total across all patients in 2023 | |||
| Armodafinil | 13 | $93.20▼ below WI avg | ≈ Typical |
About Armodafinil: Armodafinil reduces extreme sleepiness due to narcolepsy and other sleep disorders, such as periods of stopped breathing during sleep (obstructive sleep apnea). Show more ▾ It is also used to help you stay awake during work hours if you have a work schedule that keeps you from having a normal sleep routine (shift work sleep disorder). This medication does not cure these sleep disorders and may not get rid of all your sleepiness. Armodafinil does not take the place of getting enough sleep. It should not be used to treat tiredness or hold off sleep in people who do not have a sleep disorder. It is not known how armodafinil works to keep you awake. It is thought to work by affecting certain substances in the brain that control the sleep/wake cycle. A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS. In 2023, this provider wrote 13 Medicare prescriptions for Armodafinil, about 81% of the volume of the typical Wisconsin prescriber of this medication (16). Medicare paid an average of $93.20 per fill, versus $105.01 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| GlassiaAlpha-1-Proteinase Inhibitor | 12 | $9,671.02 | ≈ Typical |
About Glassia: This medication is used to treat lung problems (emphysema) caused by a certain inherited disease (alpha-1-proteinase inhibitor deficiency). Show more ▾ In people with this condition, lung damage is caused by elastase, a natural substance that the body needs to kill bacteria in the lungs. Normally, a protein (alpha-1-proteinase inhibitor) stops elastase from working when it is no longer needed. However, in people who do not make enough of this protein, elastase does not stop working and damages the lungs. This medication replaces the missing alpha-1-proteinase inhibitor and helps to prevent further lung damage. Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. In 2023, this provider wrote 12 Medicare prescriptions for Glassia, about the same volume as the typical Wisconsin prescriber of this medication (13). Medicare paid an average of $9,671.02 per fill, versus $9,128.94 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12.3 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| Clonazepam | 12 | $5.40▼ below WI avg | ▼ Less than typical |
About Clonazepam: Clonazepam is used to prevent and control seizures. Show more ▾ This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines. An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. In 2023, this provider wrote 12 Medicare prescriptions for Clonazepam, about a quarter of the volume of the typical Wisconsin prescriber of this medication (50). Medicare paid an average of $5.40 per fill, versus $9.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WI average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| AdempasRiociguat | 12 | $12,959.54 | ▼ Less than typical |
About Adempas: Riociguat is used to treat high blood pressure in the lungs (pulmonary hypertension). Show more ▾ It can also be used to treat a certain type of high blood pressure in the lungs caused by blood clots (chronic thromboembolic pulmonary hypertension) when surgery has not been fully successful or is impossible. Riociguat works by relaxing and widening the blood vessels in your lungs so blood can flow more easily. Decreasing high blood pressure in the lungs allows your heart and lungs to work better and improves your ability to exercise. In 2023, this provider wrote 12 Medicare prescriptions for Adempas, about 16% of the volume of the typical Wisconsin prescriber of this medication (74). Medicare paid an average of $12,959.54 per fill, versus $12,698.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MICHAEL F MAGUIRE M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Critical Care Medicine prescribing approach at this Appleton, WI practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among WI prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
